Academic Journals Database
Disseminating quality controlled scientific knowledge

Patient-reported outcomes of therapy with two brands of ibuprofen

ADD TO MY LIST
 
Author(s): Nwidu LL | Eniojukan JF | Oparah AC

Journal: Pharmacy Practice
ISSN 1885-642X

Volume: 6;
Issue: 3;
Start page: 142;
Date: 2008;
Original page

Keywords: Therapeutic Equivalency | Treatment Outcome | Ibuprofen | Nigeria

ABSTRACT
Objective: To investigate patients’ reported outcome following medication with two brands of 400 mg ibuprofen used to alleviate musculoskeletal pains.Methods: Adult peasant manual laborers (85) who met criteria were randomly assigned to receive either of the brands (A or B). Data on pain alleviation were gathered using the Short-Form McGill Pain Questionnaire (SF-MPQ), Visual Analogue Scale (VAS), Present Pain Intensity (PPI), and Clinical Global Impression of Improvement (CGII) scales. Interval data obtained from the two brands were compared using the Students’ t-test at 95% confidence interval.Results: There were 42 participants, mean age=29.2 (SD=1.37) assigned to brand A and 43 (mean age=28.8 SD=1.14) in brand B of ibuprofen 400 mg. Brand B was consistently rated higher than brand A. Scores for medication efficacy were 10.4 (SD=1.65) (brand A) and 11.4 (SD=1.68) (brand B); t=2.768, P=0.007. Alleviation of pain symptoms: 10.8 (SD=1.64) and 11.6 (SD=1.72); t = 2.194, P=0.031. Similarly, rated scores on the impact of pain on quality of life were 10.5 (SD=2.00) and 12.1 (SD=1.85); t=3.830, P
Why do you need a reservation system?      Save time & money - Smart Internet Solutions